Abnormally increased nitric oxide synthesis and increased endothelin‐1 in plasma in patients with obstructive sleep apnoea

References

• Lavie P., Herer P., Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. Br Med J 2000; 320: 479–82
   PubMed Web of Science ®Google Scholar
• Peppard P. E., Young T., Palta M., Skatrud J. B. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–84
   PubMed Web of Science ®Google Scholar
• Marin J. M., Carrizo S. J., Vicente E., Agusti A. G. N. Long‐term cardiovascular outcomes in men with obstructive sleep apnea‐hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–53
   PubMed Web of Science ®Google Scholar
• Foster G. E., Poulin M. J., Hanly P. J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 2006; 92: 51–65
   PubMedGoogle Scholar
• Sumpio B. E., Riley J. T., Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol 2002; 34: 1508–12
   PubMed Web of Science ®Google Scholar
• Kato M., Roberts‐Thomson P., Phillips B. G., Haynes W. G., Winnicki M., Accurso V., et al. Impairment of endothelium‐dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607–10
   PubMed Web of Science ®Google Scholar
• Lattimore J. L., Wilcox I., Skilton M., Langenfeld M., Celermajer D. S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006; 61: 491–5
   PubMed Web of Science ®Google Scholar
• Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984; 37: 217–23
   PubMed Web of Science ®Google Scholar
• Pedersen E. B., Eiskjær H., Madsen B., Danielsen H., Egeblad M., Nielsen C. B. Effects of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transpl 1993; 8: 1064–70
   PubMed Web of Science ®Google Scholar
• Jensen K. T., Carstens J., Ivarsen P., Pedersen E. B. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997; 57: 529–40
   PubMed Web of Science ®Google Scholar
• Bech J. N., Nielsen C. B., Pedersen E. B. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa and vasoactive hormones in healthy humans. Am J Physiol 1996; 39: F845–51
   Google Scholar
• Haynes W. G., Hand M. F., Dockrell M. E. C., Eadington D. W., Lee M. R., Hussein Z., et al. Physiological role of nitric oxide in regulation of renal function I humans. Am J Physiol 1997; 272: F364–71
   PubMed Web of Science ®Google Scholar
• Delles C., Klingbeil A. U., Schneider M. P., Handrock R., Schäufele T., Schmeider R. E. The role of nitric oxide in the regulation of glomerular hemodynamics in humans. Nephrol Dial Transpl 2004; 19: 1392–7
   PubMedGoogle Scholar
• Jacobi J., Schneider M. P., John S., Schneider R. E. Impact of NO‐synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. J Hypertens 2002; 20: 525–30
   PubMedGoogle Scholar
• Higashi Y., Oshima T., Ozono R., Watanabe M., Matsuura H., Kajiyama G. Effects of l‐arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension 1995; 25: 898–902
   PubMed Web of Science ®Google Scholar
• Van den Meiracker A. H., van der Linde N. A. J., Broere A., Derkx F. H. M., Boomsma F. Effects of l‐arginine and l‐NAME on the renal function in hypertensive and normotensive subjects. Nephron 2002; 91: 444–51
   PubMedGoogle Scholar
• Bech J. N., Nielsen E. H., Pedersen R. S., Svendsen K. B., Pedersen E. B. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension. Am J Hypertens 2007; 20: 287–95
   PubMed Web of Science ®Google Scholar
• Krieger J., Imps J. L., Schmidt M., Kurtz D. Renal function in patients with obstructive sleep apnea. Effects of nasal continuous positive airway pressure. Arch Intern Med 1988; 148: 1337–40
   PubMed Web of Science ®Google Scholar
• Ehlenz K., Firle K., Schneider H., Weber K., Peter J. H., Kaffarnik H., et al. Reduction of nocturnal diuresis during treatment of obstructive sleep apnea (OSA) with nasal continuous positive airway pressure (nCPAP) correlates to cGMP secretion. Med Klin 1991; 86: 294–6
   Google Scholar
• Kourembanas S., Marsden P. A., McQuillan L. P., Faller D. V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88: 1054–7
   PubMed Web of Science ®Google Scholar
• Phillips B. G., Narkiewicz K., Pesek C. A., Haynes W. G., Dyken M. E., Somers V. K. Effects of obstructive sleep apnea on endothelin‐1 and blood pressure. J Hypertens 1999; 17: 61–6
   PubMed Web of Science ®Google Scholar
• Saarelainen S., Seppälä E., Laasonen K., Hasan J. Circulating endothelin‐1 in obstructive sleep apnea. Endothelium 1997; 5: 115–18
   PubMed Web of Science ®Google Scholar
• Gjørup P. H., Sadauskiene L., Wessels J., Nyvad O., Strunge B., Pedersen E. B. Abnormally increased endothelin‐1 during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007; 20: 44–52
   PubMed Web of Science ®Google Scholar
• Møller D. C., Lind P., Strunge B., Pedersen E. B. Abnormal vasoactive hormones and 24 hour blood pressure in obstructive sleep apnea. Am J hypertens 2003; 16: 274–80
   PubMed Web of Science ®Google Scholar
• Grimpen F., Kanne P., Schulz E., Hagenah G., Hasenfuβ G., Andreas S. Endothelin‐1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 2000; 15: 320–5
   PubMed Web of Science ®Google Scholar
• Gess B., Schricker K., Pfeifer M., Kurtz A. Acute hypoxia upregulates NOS gene expression in rats. Am J Physiol 1997; 273: R905–10
   Google Scholar
• Phelan M. W., Faller D. V. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol 1996; 167: 21–8
   Google Scholar
• Phillips S. A., Olson E. B., Morgan B. J., Lombard J. H. Chronic intermittent hypoxia impairs endothelium‐dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol 2004; 286: H388–93
   Google Scholar
• Lattimore J. L., Wilcox I., Adams M. R., Kilian J. G., Celermajer D. S. Treatment of obstructive sleep apnea leads to enhanced pulmonary vascular nitric oxide release. Int J Cardiol 2007, Epub ahead of print
   PubMedGoogle Scholar
• Kraiczi H., Hedner J., Peker Y., Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000; 89: 493–8
   PubMed Web of Science ®Google Scholar
• Rubyanyi G. M., Polokoff M. A. Endothelins: molecular biology, biochemistry, pharmacology, and pathophysiology. Pharm Rev 1994; 46: 325–415
   PubMedGoogle Scholar
• Kelly L. K., Wedgwood S., Steinhorn R. H., Black S. M. Nitric oxide decreases endothelin‐1 secretion through the activation of soluble guanulate cyclase. Am J physiol 2004; 286: L984–91
   PubMed Web of Science ®Google Scholar
• Schmidt A., Bayerle‐Eder M., Pleiner H., Zeisner C., Wolzt M., Mayer G., et al. The renal and systemic effects of a nitric oxide‐synthase inhibitor are reversed by a selective endothelinA receptor antagonist in men. Nitric Oxide 2001; 5: 370–6
   PubMed Web of Science ®Google Scholar
• Montanari A., Biggi A., Carra N., Fasoli E., Calzolari M., Corsini F., et al. Endothelin‐A blockade attenuates systemic and renal hemodynamic effects of l‐NAME in humans. Hypertension 2000; 35: 518–23
   PubMed Web of Science ®Google Scholar
• Rubens C., Ewert R., Halank M., Wensel R., Orzechowski H‐D., Schultheiss H–P., et al. Big endothelin‐1 and endothelin‐1 plasma levels are correlated with severity of primary pulmonary hypertension. Chest 2001; 120: 1562–9
   PubMed Web of Science ®Google Scholar
• Koomans H. A., Boer W. H., Mees E. J. D. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989; 36: 2–12
   PubMed Web of Science ®Google Scholar
• DeSouza C. A., van Guilder G. P., Greiner J. J., Smith D. T., Hoetzer G. L., Stauffer B. L. Basal endothelial nitric oxide release is preserved in overweight and obese adults. Obes Res 2005; 13: 1303–6
   PubMedGoogle Scholar
• Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Chayama K., Oshima T. Effect of obesity on endothelium‐dependent nitric oxide‐mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001; 14: 1038–45
   PubMed Web of Science ®Google Scholar
• Rask‐Madsen C., King G. L. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrin Metabol 2007; 3: 46–56
   PubMedGoogle Scholar
• Bech J. N., Nielsen C. B., Ivasen P., Jenssen K. T., Pedersen E. B. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol 1998; 274: F914–23
   PubMed Web of Science ®Google Scholar